Myprostatecancertreatment.org

Website Ranking Data
Current Alexa Rank

183,657

Updated Jun 02 2021
Historical Rank
Myprostatecancertreatment.org historical owner info, name servers, Analytics ID, Adsense ID, Addthis ID, advertisers, screenshots, meta tags, whois, site and server info.
Estimated Visitors

16,729

Daily Unique Visitors

518,602

Monthly Visitors

6,223,224

Yearly Visitors
Domain Information
Registrar Register.com, Inc. (R71-LROR)
Created 12.04.2011
Updated 23.09.2013
Expiration 12.04.2017
Name Server Information
udns1.ultradns.net
udns2.ultradns.net
Web Server Information
IP Address 204.74.99.100
Server Response 200
Web Server Microsoft-IIS/8.5
Updated: 2018-02-12
Top related sites:
Top prostate sites
Top cancer sites
Top treatment sites
Meta Tags and Data
Title
Prostate Cancer Treatment Guide | MyProstateCancerTreatment.org
Meta Description
Make an informed decision about your prostate cancer treatment. Learn more about how the Oncotype DX test can help you personalize your treatment plan.
Meta Keywords
prostate cancer, prostate cancer treatment, prostate cancer patients, prostate cancer recurrence, active surveillance, oncotype dx prostate cancer assay, prostate cancer test, prostate cancer diagnosis, prostate cancer doctors, prostate cancer information, your prostate your decision
Technologies in use
Google Analytics, AddThis, jQuery, FastClick, Modernizr, Head JS
Archived Meta Tags Updated: 2018-02-12
Whois Information
Name
Genomic Health
Organization
Genomic Health, Inc
Street
301 Penobscot Drive
City
Redwood City
Postal Code
94063
Country
UNITED STATES
Phone
16505569300
Archived Whois Data Updated: 2015-11-15
Server Response
Pragmano-cache
Content-Typetext/html; charset=utf-8
Last-ModifiedTue, 12 Dec 2017 15:42:32 GMT
ServerMicrosoft-IIS/8.5
X-FRAME-OPTIONSSAMEORIGIN
VaryAccept-Encoding
Content-Encodinggzip
Cache-Controlno-cache, no-store
ExpiresMon, 12 Feb 2018 06:47:23 GMT
Connectionkeep-alive
Updated: 2018-02-12
Related sites
Sites related to Myprostatecancertreatment.org based on metadata.